Literature DB >> 12717247

Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases.

Markku Miettinen1, Janusz Kopczynski, Hala R Makhlouf, Maarit Sarlomo-Rikala, Hajnalka Gyorffy, Allen Burke, Leslie H Sobin, Jerzy Lasota.   

Abstract

In this study we analyzed the clinicopathologic features of duodenal smooth muscle or stromal tumors, including 156 GISTs, 6 leiomyomas (LMs), and 5 leiomyosarcomas (LMSs) from the files of the Armed Forces Institute of Pathology and the Haartman Institute of the University of Helsinki. GISTs were documented as KIT positive (n = 109); 47 tumors were also included because of their histologic identity to KIT-positive cases. GIST-specific c-kit gene mutations were documented in exon 11 in 9 of 30 cases (30%) and exon 9 in 4 of 30 cases (13%). The GISTs occurred in patients with an age range of 10-88 years (median 56 years); 54% were male. Ten patients had neurofibromatosis type I; six of them had multiple GISTs. The GISTs ranged from small asymptomatic intramural or external nodules to large masses that extended into the retroperitoneum (median size 4.5 cm). They were mostly spindle cell tumors; three malignant GISTs had an epithelioid morphology, and 81 cases had skeinoid fibers. The tumors often coexpressed CD34 and KIT (54%) and were variably positive for smooth muscle actin (39%) and S-100 protein (20%) but never for desmin. A total of 86% of patients with tumors >5 cm with >5 mitoses/50 high power fields (HPF) (n = 21) died of disease, whereas no tumor <2 cm with <5 mitoses/50 HPF (n = 12) recurred or caused death. Long latency was common between primary operation and recurrences or metastases; either one occurred in 49 of 140 patients with follow-up (35%). No formula could accurately predict metastases, which occasionally developed even if mitotic activity was <5/50 HPF and size <5 cm. Metastases were in the abdominal cavity, liver, and rarely in bones and lungs but never in lymph nodes. Four actin- and desmin-positive and KIT-negative benign intramural LMs were similar to those more often seen in the esophagus. There were five LMSs, one of which formed a polypoid intraluminal mass; all were actin positive and KIT negative. The great majority of duodenal mesenchymal tumors are GISTs, which have a spectrum from small indolent tumors to overt sarcomas. LMs and LMSs are rare.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717247     DOI: 10.1097/00000478-200305000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  114 in total

1.  Segmental duodenectomy for gastrointestinal stromal tumor of the duodenum.

Authors:  Nicolas Christian Buchs; Pascal Bucher; Pascal Gervaz; Sandrine Ostermann; François Pugin; Philippe Morel
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

2.  A Gastrointestinal Stromal Tumor Presenting as an Emergency: a Case Report.

Authors:  Konstantinos Bouliaris; Aikaterini Michopoulou; Konstantinos Spanos; Vassilios Simopoulos; Ioannis Bolanis; Stylianos Germanos
Journal:  J Gastrointest Cancer       Date:  2012-09

3.  Commentary to: Atypical Presentation of Gastrointestinal Stromal Tumours-A Case Report by Kalpana Raja et al.

Authors:  Dharmendra Mehta
Journal:  Indian J Surg       Date:  2014-05-14       Impact factor: 0.656

Review 4.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

5.  Segmental duodenectomy with duodenojejunostomy of gastrointestinal stromal tumor involving the duodenum.

Authors:  Jun Chul Chung; Hyung Chul Kim; Chong Woo Chu
Journal:  J Korean Surg Soc       Date:  2011-06-17

6.  Analysis of CD117-negative gastrointestinal stromal tumors.

Authors:  Chin-Yuan Tzen; Bey-Liing Mau
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

7.  Comparison between air and carbon dioxide insufflation in the endoscopic submucosal excavation of gastrointestinal stromal tumors.

Authors:  Wei-Bin Shi; Zi-Hao Wang; Chun-Ying Qu; Yi Zhang; Han Jiang; Min Zhou; Ying Chen; Lei-Ming Xu
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

8.  Duodenal gastrointestinal stromal tumors (GISTs): arguments for conservative surgery.

Authors:  Stéphane Bourgouin; Emmanuel Hornez; Jérôme Guiramand; Louise Barbier; Jean-Robert Delpero; Yves-Patrice Le Treut; Vincent Moutardier
Journal:  J Gastrointest Surg       Date:  2012-11-15       Impact factor: 3.452

9.  p16 expression differentiates high-risk gastrointestinal stromal tumor and predicts poor outcome.

Authors:  Michael Schmieder; Sebastian Wolf; Bettina Danner; Susanne Stoehr; Markus S Juchems; Peter Wuerl; Doris Henne-Bruns; Uwe Knippschild; Cornelia Hasel; Klaus Kramer
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

10.  Detection of treatment-induced changes in signaling pathways in gastrointestinal stromal tumors using transcriptomic data.

Authors:  Michael F Ochs; Lori Rink; Chi Tarn; Sarah Mburu; Takahiro Taguchi; Burton Eisenberg; Andrew K Godwin
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.